Tectonic Therapeutic (TECX) Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) reported Current Assets of $239.9 million for Q1 2026, down 22.53% year-over-year from $309.6 million in Q1 2025, and down 6.79% quarter-over-quarter from $257.4 million in Q4 2025.
Tectonic Therapeutic (TECX) Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Current Assets data on file, last reported at $239.9 million in Q1 2026.
- Current Assets for Q1 2026 came in at $239.9 million, down 22.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $239.9 million (down 22.53% YoY), and the FY2025 annual result was $257.4 million, up 75.24% from the prior year.
- Current Assets fell to $239.9 million in Q1 2026 per TECX's latest filing, from $257.4 million in the prior quarter.
- Over five years, Current Assets peaked at $309.6 million in Q1 2025 and troughed at $30.9 million in Q4 2023.
- A 5-year average of $167.4 million and a median of $146.9 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 69.1% in 2023, then soared 375.51% in 2024.
- A 5-year view of Current Assets shows it stood at $100.0 million in 2022, then slumped by 69.1% to $30.9 million in 2023, then jumped by 375.51% to $146.9 million in 2024, then soared by 75.24% to $257.4 million in 2025, then decreased by 6.79% to $239.9 million in 2026.
- Business Quant data shows TECX's Current Assets at $239.9 million in Q1 2026, $257.4 million in Q4 2025, and $273.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 239.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.89 Mn |
| Dec 31, 2025 | 257.36 Mn |
| Sep 30, 2025 | 273.24 Mn |
| Jun 30, 2025 | 290.85 Mn |
| Mar 31, 2025 | 309.64 Mn |
| Dec 31, 2024 | 146.86 Mn |
| Sep 30, 2024 | 162.60 Mn |
| Jun 30, 2024 | 187.39 Mn |
| Mar 31, 2024 | 91.84 Mn |
| Dec 31, 2023 | 30.88 Mn |
| Sep 30, 2023 | 109.17 Mn |
| Jun 30, 2023 | 128.84 Mn |
| Mar 31, 2023 | 77.25 Mn |
| Dec 31, 2022 | 99.96 Mn |
| Sep 30, 2022 | 126.23 Mn |
| Jun 30, 2022 | 142.08 Mn |
| Mar 31, 2022 | 170.92 Mn |
| Dec 31, 2021 | 199.15 Mn |
| Sep 30, 2021 | 211.66 Mn |
| Jun 30, 2021 | 233.52 Mn |